Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis.
Rubino M, Di Stasio GD, Bodei L, Papi S, Rocca PA, Ferrari ME, Fodor CI, Bagnardi V, Frassoni S, Mei R, Fazio N, Ceci F, Grana CM. Rubino M, et al. Among authors: ceci f. Endocrine. 2024 May;84(2):704-710. doi: 10.1007/s12020-024-03707-5. Epub 2024 Feb 7. Endocrine. 2024. PMID: 38324106
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study.
Volpe S, Zaffaroni M, Piperno G, Vincini MG, Zerella MA, Mastroleo F, Cattani F, Fodor CI, Bellerba F, Bonaldi T, Bonizzi G, Ceci F, Cremonesi M, Fusco N, Gandini S, Garibaldi C, Torre D, Noberini R, Petralia G, Spaggiari L, Venetis K, Orecchia R, Casiraghi M, Jereczek-Fossa BA. Volpe S, et al. Among authors: ceci f. BMC Cancer. 2023 Dec 15;23(1):1236. doi: 10.1186/s12885-023-11701-9. BMC Cancer. 2023. PMID: 38102575 Free PMC article.
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE".
Marvaso G, Corrao G, Repetti I, Lorubbio C, Bellerba F, Zaffaroni M, Vincini MG, Zerini D, Alessi S, Luzzago S, Mistretta FA, Fodor C, Cambria R, Cattani F, Ceci F, Musi G, De Cobelli O, Zilli T, Gandini S, Orecchia R, Petralia G, Jereczek-Fossa BA. Marvaso G, et al. Among authors: ceci f. World J Urol. 2024 Mar 16;42(1):169. doi: 10.1007/s00345-024-04876-8. World J Urol. 2024. PMID: 38492078
A PET-Surrogate Signature for the Interrogation of the Metabolic Status of Breast Cancers.
Confalonieri S, Matoskova B, Pennisi R, Martino F, De Mario A, Miloro G, Montani F, Rotta L, Ferrari ME, Gilardi L, Ceci F, Grana CM, Rizzuto R, Mammucari C, Di Fiore PP, Lanzetti L. Confalonieri S, et al. Among authors: ceci f. Adv Sci (Weinh). 2024 May 17:e2308255. doi: 10.1002/advs.202308255. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38757578
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis.
Corrao G, Marvaso G, Mastroleo F, Biffi A, Pellegrini G, Minari S, Vincini MG, Zaffaroni M, Zerini D, Volpe S, Gaito S, Mazzola GC, Bergamaschi L, Cattani F, Petralia G, Musi G, Ceci F, De Cobelli O, Orecchia R, Alterio D, Jereczek-Fossa BA. Corrao G, et al. Among authors: ceci f. Radiother Oncol. 2024 Jun;195:110264. doi: 10.1016/j.radonc.2024.110264. Epub 2024 Mar 30. Radiother Oncol. 2024. PMID: 38561122
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature.
Piperno G, Ferrari A, Volpe S, Cattani F, Zaffaroni M, Comi S, Pansini F, Bergamaschi L, Mazzola GC, Ceci F, Colandrea M, Petralia G, Orecchia R, Jereczek-Fossa BA, Alterio D. Piperno G, et al. Among authors: ceci f. Crit Rev Oncol Hematol. 2023 Nov;191:104114. doi: 10.1016/j.critrevonc.2023.104114. Epub 2023 Sep 6. Crit Rev Oncol Hematol. 2023. PMID: 37683814 Review.
264 results